Physician

Rhonda W. Gabr, M.D.

According to 2025 Medicare claims, Rhonda Gabr, M.D. (NPI: 1609803949) practices neurology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is RALEIGH NEUROLOGY ASSOCIATES, P. A. (NPI: 1215954003; TIN: 562002729) and primary practice location at 27607-5253.

Gabr's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 320 traditional Medicare patients, billed 63,508 HCPCS/CPT codes, and received $931,925 in Medicare payments. The top billing code was 64615 (Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face). Part D data shows 1,776 prescription claims across 284 beneficiaries totaling $848,260 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2017 DME data shows 11 claims. Open Payments data shows 26 records totaling $665. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $149,124 to $931,925. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $494,820 and ending at $848,260. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $6,996 to $930.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	536	13,244	$149,124
2016	572	26,454	$251,690
2017	556	33,421	$376,672
2018	540	30,651	$310,356
2019	484	31,394	$394,402
2020	428	31,319	$507,021
2021	385	29,577	$342,411
2022	406	31,073	$216,541
2023	337	59,159	$935,825
2024	320	63,508	$931,925

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	331	2,091	$494,820
2016	321	1,913	$248,943
2017	385	2,351	$586,393
2018	400	2,224	$305,959
2019	340	1,622	$173,264
2020	317	1,579	$377,859
2021	336	1,487	$530,982
2022	281	1,388	$474,622
2023	254	1,591	$744,600
2024	284	1,776	$848,260

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$85
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64615	Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face	56	167	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	53	64	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	50	94	$61
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	49	101	$38
J0585	Injection, onabotulinumtoxina, 1 unit	55	33,800	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	30	751	$537,822
Nurtec Odt	Rimegepant Sulfate	51	1,258	$62,091
Emgality Pen	Galcanezumab-Gnlm	47	1,502	$40,644
Aimovig Autoinjector	Erenumab-Aooe	32	956	$23,383
Ubrelvy	Ubrogepant	14	280	$17,223

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$665	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rhonda W. Gabr, M.D.?

Tedicare shows public-source Medicare data for Rhonda W. Gabr, M.D. (NPI 1609803949), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rhonda W. Gabr, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rhonda W. Gabr, M.D.?

Rhonda W. Gabr, M.D. is linked to RALEIGH NEUROLOGY ASSOCIATES, P. A. (billing NPI 1215954003) in the available physician profile data.

Does Rhonda W. Gabr, M.D. have Open Payments data?

Rhonda W. Gabr, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.